Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Prichard

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|September 9, 2008
Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastomaColeman J Bryan, Mark N Prichard, Shannon Daily, et al.
Bioorganic & Medicinal Chemistry|July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replicationNadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Benzimidazole analogs inhibit human herpesvirus 6Mark N Prichard, Samuel L Frederick, Shannon Daily, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2016
Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family membersAlexandra Manos-Turvey, Hiba A Al-Ashtal, Patrick G Needham, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2011
Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agentsNorbert Schormann, Charnell Inglis Sommers, Mark N Prichard, et al.
The Journal of Infectious Diseases|March 5, 2016
Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir ProphylaxisE Randall Lanier, Scott Foster, Tom Brundage, et al.
Organic & Biomolecular Chemistry|December 22, 2018
Synthesis of A-ring quinolones, nine-membered oxolactams and spiroindoles by oxidative transformations of 2,3-indolotriterpenoidsElmira F Khusnutdinova, Oxana B Kazakova, Alexander N Lobov, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2008
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infectionsEarl R Kern, Mark N Prichard, Debra C Quenelle, et al.
Virology Journal|May 16, 2008
Isolation and characterization of cidofovir resistant vaccinia virusesMarie N Becker, Maria Obraztsova, Earl R Kern, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2007
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxvirusesDebra C Quenelle, Mark N Prichard, Kathy A Keith, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|September 9, 2008
Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastomaColeman J Bryan, Mark N Prichard, Shannon Daily, et al.
Bioorganic & Medicinal Chemistry|July 2, 2011
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replicationNadejda Valiaeva, David L Wyles, Robert T Schooley, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Benzimidazole analogs inhibit human herpesvirus 6Mark N Prichard, Samuel L Frederick, Shannon Daily, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2016
Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family membersAlexandra Manos-Turvey, Hiba A Al-Ashtal, Patrick G Needham, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2011
Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agentsNorbert Schormann, Charnell Inglis Sommers, Mark N Prichard, et al.
The Journal of Infectious Diseases|March 5, 2016
Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir ProphylaxisE Randall Lanier, Scott Foster, Tom Brundage, et al.
Organic & Biomolecular Chemistry|December 22, 2018
Synthesis of A-ring quinolones, nine-membered oxolactams and spiroindoles by oxidative transformations of 2,3-indolotriterpenoidsElmira F Khusnutdinova, Oxana B Kazakova, Alexander N Lobov, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2008
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infectionsEarl R Kern, Mark N Prichard, Debra C Quenelle, et al.
Virology Journal|May 16, 2008
Isolation and characterization of cidofovir resistant vaccinia virusesMarie N Becker, Maria Obraztsova, Earl R Kern, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2007
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxvirusesDebra C Quenelle, Mark N Prichard, Kathy A Keith, et al.
Pageof 8